|
Avaliação DCF Zivo Bioscience, Inc. (Zivo)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
ZIVO Bioscience, Inc. (ZIVO) Bundle
Explore as perspectivas financeiras Zivo Bioscience, Inc. (Zivo) usando nossa calculadora DCF amigável! Digite suas suposições de crescimento, margens e despesas para calcular o valor intrínseco do Zivo e aprimorar sua abordagem de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | -100 | 0 | 0 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -8.4 | -.6 | -9.1 | -8.7 | -7.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | -2750.27 | 100 | 100 | -26267.67 | 20 | 20 | 20 | 20 | 20 |
| Depreciation | 8.4 | 8.6 | -.4 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 42778.38 | 100 | 100 | 0 | 80 | 80 | 80 | 80 | 80 |
| EBIT | -16.7 | -9.1 | -8.6 | -8.7 | -7.3 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | -45528.64 | 100 | 100 | -26267.67 | 20 | 20 | 20 | 20 | 20 |
| Total Cash | .3 | .1 | 8.9 | 1.8 | .3 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 0 | 100 | 100 | 13.51 | 62.7 | 62.7 | 62.7 | 62.7 | 62.7 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 0 | 100 | 100 | 0 | 60 | 60 | 60 | 60 | 60 |
| Accounts Payable | 1.4 | 1.6 | .7 | .5 | 1.2 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 7798.14 | 100 | 100 | 4216.13 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -21.3 | -9.7 | -8.9 | -8.7 | -7.3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -11.6 | -.9 | -10.2 | -8.9 | -6.6 | -1.1 | .0 | .0 | .0 | .0 |
| WACC, % | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -1 | |||||||||
| Diluted Shares Outstanding, MM | 2 | |||||||||
| Equity Value Per Share | -0.59 |
What You Will Get
- Real ZIVO Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for ZIVO Bioscience, Inc. (ZIVO).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to ZIVO.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on ZIVO’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for ZIVO.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility in your analysis of ZIVO.
Key Features
- Comprehensive Data: ZIVO's historical performance metrics and pre-filled projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Observe ZIVO’s intrinsic value update instantly.
- Intuitive Visualizations: Dashboard graphs showcase valuation outcomes and essential metrics.
- Designed for Precision: An expert tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered ZIVO data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for ZIVO’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for ZIVO Bioscience, Inc. (ZIVO)?
- Accurate Data: Utilize real ZIVO financials for dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Built-in calculations save you from starting from scratch.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Investors: Evaluate ZIVO’s market position before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess future forecasts.
- Startup Founders: Understand the valuation strategies of successful biotech companies like ZIVO.
- Consultants: Provide detailed valuation analyses for clients in the biotech sector.
- Students and Educators: Utilize current data to learn and teach valuation principles in biotechnology.
What the Template Contains
- Preloaded ZIVO Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.